Evidence map›Paper›PMID 34721900›Full record

ArticleAnemia2021

Orofacial Manifestation and Dental Management of Sickle Cell Disease: A Scoping Review.

Mayank Kakkar, Kristen Holderle, Megha Sheth, Szilvia Arany, Leslie Schiff, Adela Planerova

Open access · goldAbstract readScoping Review
In one paragraph

Article in Anemia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Does Sickle Cell Anaemia Have a Relationship With Avascular Pulp Necrosis? A Systematic Review.Australian endodontic journal : the journal of the Australian Society of Endodontology Inc · 2026
    Pooled it
  2. Mandibular Radiographic Assessment in Sickle Cell Disease: A Systematic Review of Radiomorphometric Indices and Fractal Dimension.Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Clinical Vignettes, Part II: Eyes, Teeth, and Bone.Hematology/oncology clinics of North America · 2022
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mayank KakkarDepartment of General Dentistry, Eastman Institute for Oral Health, University of Rochester, Rochester, NY, USA.ORCID https://orcid.org/0000-0002-9721-4480
Kristen HolderleDepartment of Psychiatry and Pediatrics, University of Rochester Medical Center, Rochester, NY, USA.ORCID https://orcid.org/0000-0003-2500-9880
Megha ShethDepartment of General Dentistry, Eastman Institute for Oral Health, University of Rochester, Rochester, NY, USA.ORCID https://orcid.org/0000-0001-7862-6597
Szilvia AranyDepartment of General Dentistry, Eastman Institute for Oral Health, University of Rochester, Rochester, NY, USA.ORCID https://orcid.org/0000-0002-0021-7088
Leslie SchiffDepartment of General Dentistry, Eastman Institute for Oral Health, University of Rochester, Rochester, NY, USA.ORCID https://orcid.org/0000-0002-6536-0870
Adela PlanerovaDepartment of General Dentistry, Eastman Institute for Oral Health, University of Rochester, Rochester, NY, USA.ORCID https://orcid.org/0000-0002-9002-8685
Eastman Chemical Company (United States) · USUniversity of Rochester Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsSickle cell disease (SCD) is an upcoming global health problem with rapid progress in therapy especially since 2017. However, systematic reviews found no clinical trials on the dental treatment of sickle cell disease (SCD). This article aims to outline the oral features of the sickle disease and discuss oral management strategies that can serve as guidelines for dental professionals.

resultsThe results of this study demonstrate that there is distinct evidence available, indicating the developmental enamel defect leading to hypoplasia and increasing susceptibility to dental caries. Another important result of this review found that people with SCD have a vaso-occlusive crisis in the microcirculation in the dental pulp leading to symptomatic and asymptomatic pulpal necrosis without any signs of odontogenic pathology in an apparently healthy tooth. The study also found that early detection, intervention, and prevention are crucial for improving oral health care, and involving a multidisciplinary approach plays an important role in managing people with SCD.

conclusionPatients with sickle cell disease have chronic overall health problems. The hematological disorder becomes their main concern and impaired oral health becomes secondary, increasing the risk for dental caries at the most. This paper broadly describes the oral manifestations of SCD, additionally; this paper also provides recommendations for better dental management of patients with SCD. Patients with SCD are often misjudged and, due to lack of knowledge and guidelines, dental providers are not able to provide adequate care. This paper attempts to highlight the essential measures to provide better dental care.

Identifiers

PMID34721900
PMCPMC8556080
OpenAlexW3210771639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.